IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

Equity Bottom-Up

Saratoga Investama Sedaya / Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/saratoga-investama-sedaya-tbk-pt" target="_blank" data-smartkarma-citation="entities:13714:1" rel="noopener">Saratoga Investama Sedaya (SRTG IJ)</a> is an active Indonesian investment firm with an exceptional track record of profitable investments across sectors. </li>
<li>The current NAV discount of 34% should continue to narrow as SRTG continues to burnish its ESG credentials and deliver significant realization of divestment gains. </li>
<li>Our SOTP valuation assumes a 25% NAV discount implying a 14% upside to the last close price. We are buyers.</li>
</ul>



Saratoga Investama Sedaya (SRTG IJ) is an active Indonesian investment firm with an exceptional track record of profitable investments across sectors. 
The current NAV discount of 34% should continue to narrow as SRTG continues to burnish its ESG credentials and deliver significant realization of divestment gains. 
Our SOTP valuation assumes a 25% NAV discount implying a 14% upside to the last close price. We are buyers.


Saratoga Investama Sedaya (SRTG IJ): A Track Record to Narrow the NAV Discount

Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

<ul>
<li>Fund manager <a href="https://www.smartkarma.com/entities/saratoga-investama-sedaya-tbk-pt" target="_blank" data-smartkarma-citation="entities:13714:1" rel="noopener">Saratoga Investama Sedaya (SRTG IJ)</a> is up 107% yoy, buoyed by its investment holdings in <a href="https://www.smartkarma.com/entities/merdeka-copper-gold-tbk-pt" target="_blank" data-smartkarma-citation="entities:28447:1" rel="noopener">Merdeka Copper Gold (MDKA IJ)</a> and <a href="https://www.smartkarma.com/entities/adaro-energy-tbk-pt" target="_blank" data-smartkarma-citation="entities:6061:1" rel="noopener">Adaro Energy (ADRO IJ)</a>.</li>
<li>The discount to NAV is ~31% against a one-year average of 37%.</li>
<li>Potential large divestments, such as its holding in <a href="https://www.smartkarma.com/entities/tower-bersama-infrastructure" target="_blank" data-smartkarma-citation="entities:3537:1" rel="noopener">Tower Bersama Infrastructure (TBIG IJ)</a>, could causer investors to substantially narrow the NAV discount. </li>
</ul>


Fund manager Saratoga Investama Sedaya (SRTG IJ) is up 107% yoy, buoyed by its investment holdings in Merdeka Copper Gold (MDKA IJ) and Adaro Energy (ADRO IJ).
The discount to NAV is ~31% against a one-year average of 37%.
Potential large divestments, such as its holding in Tower Bersama Infrastructure (TBIG IJ), could causer investors to substantially narrow the NAV discount. 


Unlocking Saratoga Investama (SRTG IJ)'s Holdco

Pan-Asia Index Rebalances/ Events/ Delta One, Periscope Analytics

Brian Freitas

Pan-Asia Index Rebalances/ Events/ Delta One

Index Rebalance

<ul>
<li>At the January review, there are 2 changes to the IDX30 Index, 5 changes to the LQ45 Index, and 9 changes to the IDX30 Index.</li>
<li>Largest buying impact will be on <a href="https://www.smartkarma.com/entities/sumber-alfaria-trijaya-tbk-pt" target="_blank" data-smartkarma-citation="entities:15659:1" rel="noopener">Sumber Alfaria Trijaya Tbk Pt</a>, <a href="https://www.smartkarma.com/entities/elang-mahkota-teknologi-tbk" target="_blank" data-smartkarma-citation="entities:7752:1" rel="noopener">Emtek (EMTK IJ)</a>, <a href="https://www.smartkarma.com/entities/waskita-karya-persero-tbk-pt" target="_blank" data-smartkarma-citation="entities:15739:1" rel="noopener">Waskita Karya (Persero) (WSKT IJ)</a>, <a href="https://www.smartkarma.com/entities/bfi-finance-indonesia-tbk-pt" target="_blank" data-smartkarma-citation="entities:8447:1" rel="noopener">BFI Finance Indonesia (BFIN IJ)</a> and <a href="https://www.smartkarma.com/entities/xl-axiata-tbk-pt" target="_blank" data-smartkarma-citation="entities:15028:1" rel="noopener">XL Axiata (EXCL IJ)</a>. </li>
<li>Largest selling impact will be on <a href="https://www.smartkarma.com/entities/ace-hardware-indonesia" target="_blank" data-smartkarma-citation="entities:12808:1" rel="noopener">Ace Hardware Indonesia (ACES IJ)</a>, <a href="https://www.smartkarma.com/entities/jasa-marga-persero-tbk-pt" target="_blank" data-smartkarma-citation="entities:12747:1" rel="noopener">Jasa Marga (JSMR IJ)</a>, <a href="https://www.smartkarma.com/entities/pakuwon-jati-tbk-pt" target="_blank" data-smartkarma-citation="entities:8550:1" rel="noopener">Pakuwon Jati (PWON IJ)</a> , <a href="https://www.smartkarma.com/entities/bumi-serpong-damai-pt" target="_blank" data-smartkarma-citation="entities:15498:1" rel="noopener">Bumi Serpong Damai (BSDE IJ)</a> and <a href="https://www.smartkarma.com/entities/hm-sampoerna-tbk-pt" target="_blank" data-smartkarma-citation="entities:617:1" rel="noopener">HM Sampoerna (HMSP IJ)</a>.</li>
</ul>


At the January review, there are 2 changes to the IDX30 Index, 5 changes to the LQ45 Index, and 9 changes to the IDX30 Index.
Largest buying impact will be on Sumber Alfaria Trijaya Tbk Pt, Emtek (EMTK IJ), Waskita Karya (Persero) (WSKT IJ), BFI Finance Indonesia (BFIN IJ) and XL Axiata (EXCL IJ). 
Largest selling impact will be on Ace Hardware Indonesia (ACES IJ), Jasa Marga (JSMR IJ), Pakuwon Jati (PWON IJ) , Bumi Serpong Damai (BSDE IJ) and HM Sampoerna (HMSP IJ).


IDX30/LQ45 Index Rebalance: BIG Impact Changes in Limited Time

ASEAN Insight Provider, CrossASEAN Research

Angus Mackintosh

ASEAN Insight Provider

CrossASEAN Research

At CrossASEAN Research we strive to produce unbiased and differentiated on the ground insights on companies across South East Asia. Our Research is produced for the most part after face to face meetings and conversations with company management to dig deep into the long term vision and strategy of the companies we cover. We seek to deliver investable and actionable themes on sectors and markets across SE Asia, often in collaboration with other Insight Providers across the region, pooling the vast experience of the analysts within the Smartkarma Ecosystem. We also offer bespoke work and tailor made trips for our clients. 

Insights across South East Asia

<div class="content-highlight">
We continue to take a positive view on <a href="https://www.smartkarma.com/entities/industri-jamu-dan-farmasi-sido-muncul-tbk-pt" target="_blank" data-smartkarma-citation="entities:6033:1" rel="noopener">Sido Muncul (SIDO IJ)</a> as an increasingly interesting consumer health play for Indonesia, with its main brand a household name, with signs that its product diversification has gained significant traction both in beverages and supplements.
</div>
<a href="https://www.smartkarma.com/entities/industri-jamu-dan-farmasi-sido-muncul-tbk-pt" target="_blank" data-smartkarma-citation="entities:6033:1" rel="noopener">Sido Muncul (SIDO IJ)</a> recently released a very solid set of results for 3Q2021, with sales growing by +41% YoY , bringing 9M2021 sales growth to +23% YoY driven by improving consumer sentiment, with sustained growth from its leading products, and a higher contribution from new products.
It has also extended its distribution channel to 131,000 wholesalers and retailers for 9M2021 covering over 100,000 outlets and has further embraced digital channels, now selling through around 20 external marketplaces.
The company also saw improved margins in 3Q2021, with the gross margin improvement driven by stable raw material prices, operational efficiencies, and effective cost controls.
<a href="https://www.smartkarma.com/entities/industri-jamu-dan-farmasi-sido-muncul-tbk-pt" target="_blank" data-smartkarma-citation="entities:6033:1" rel="noopener">Sido Muncul (SIDO IJ)</a> has benefitted from the increasing health consciousness amongst Indonesian consumers and saw the sales of its core product Tolok Angin grow by +40% YoY  3Q2021. 
The company has continued to diversify its product offering with its new products (NPD) seeing a growth rate of more than +140% QoQ in 3Q2021.
<a href="https://www.smartkarma.com/entities/industri-jamu-dan-farmasi-sido-muncul-tbk-pt" target="_blank" data-smartkarma-citation="entities:6033:1" rel="noopener">Sido Muncul (SIDO IJ)</a> continues to focus on improving its ESG ratings and recently saw the <a href="https://www.smartkarma.com/entities/industri-jamu-dan-farmasi-sido-muncul-tbk-pt" target="_blank" data-smartkarma-citation="entities:6033:1" rel="noopener">Sido Muncul (SIDO IJ)</a> rating reduced to low-risk by Sustainalytics.
<section class="figure"><a href="https://www.smartkarma.com/entities/industri-jamu-dan-farmasi-sido-muncul-tbk-pt" target="_blank" data-smartkarma-citation="entities:6033:1" rel="noopener">Sido Muncul (SIDO IJ)</a> maintains an optimistic outlook for this year and 2022 as the economic recovery kicks in together with an increased focus on a healthy lifestyle.</section>


We continue to take a positive view on Sido Muncul (SIDO IJ) as an increasingly interesting consumer health play for Indonesia, with its main brand a household name, with signs that its product diversification has gained significant traction both in beverages and supplements.

Sido Muncul (SIDO IJ) recently released a very solid set of results for 3Q2021, with sales growing by +41% YoY , bringing 9M2021 sales growth to +23% YoY driven by improving consumer sentiment, with sustained growth from its leading products, and a higher contribution from new products.
It has also extended its distribution channel to 131,000 wholesalers and retailers for 9M2021 covering over 100,000 outlets and has further embraced digital channels, now selling through around 20 external marketplaces.
The company also saw improved margins in 3Q2021, with the gross margin improvement driven by stable raw material prices, operational efficiencies, and effective cost controls.
Sido Muncul (SIDO IJ) has benefitted from the increasing health consciousness amongst Indonesian consumers and saw the sales of its core product Tolok Angin grow by +40% YoY  3Q2021. 
The company has continued to diversify its product offering with its new products (NPD) seeing a growth rate of more than +140% QoQ in 3Q2021.
Sido Muncul (SIDO IJ) continues to focus on improving its ESG ratings and recently saw the Sido Muncul (SIDO IJ) rating reduced to low-risk by Sustainalytics.
Sido Muncul (SIDO IJ) maintains an optimistic outlook for this year and 2022 as the economic recovery kicks in together with an increased focus on a healthy lifestyle.

Sido Muncul (SIDO IJ) - A Consumer Health Gem

Quality-Value Investing

Marc Melendez, CFA

Emerging Market Small and Mid Cap Equities

Reperio Capital

Reperio Capital Research was founded in 2013 with the goal of better serving the investment community with in-depth, high quality, value oriented research.

Reperio means to discover in latin. Using value investing principles, we aim to discover a minimum of 12 investment opportunities per year within the Emerging Markets Small and Mid Cap universe.

We take a business owners perspective with a long term investment horizon. We conduct bottom up, fundamental research. We focus on downside risks and require a significant margin of safety in any investment to prevent the permanent loss of capital. All factors differentiating our research from the short term, trading focus of traditional research providers.

Tower Bersama Infrastructure / Equity Bottom-Up

This report is an in-depth look at <a href="https://www.smartkarma.com/entities/3537" target="_blank" data-smartkarma-citation="entities:3537:1">Tower Bersama Infrastructure (TBIG IJ)</a>, the second largest independent tower company in Indonesia. It operates in an industry with economies of scale, high switching costs, operating leverage, and good growth prospects. Despite the attractiveness of the industry, its largest competitor, <a href="https://www.smartkarma.com/entities/6848" target="_blank" data-smartkarma-citation="entities:6848:1">Sarana Menara Nusantara Pt (TOWR IJ)</a> is the preferred investment opportunity as it is more operationally efficient, has greater capital efficiency, is in stronger financial health, has more conservative management, who are better capital allocators, and it is cheaper.<figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/054/317/original/Key%20Stats.png?1528118949" class="editor-image img-responsive" data-smartkarma-image-id="54317"></figure>

This report is an in-depth look at Tower Bersama Infrastructure (TBIG IJ), the second largest independent tower company in Indonesia. It operates in an industry with economies of scale, high switching costs, operating leverage, and good growth prospects. Despite the attractiveness of the industry, its largest competitor, Sarana Menara Nusantara Pt (TOWR IJ) is the preferred investment opportunity as it is more operationally efficient, has greater capital efficiency, is in stronger financial health, has more conservative management, who are better capital allocators, and it is cheaper.

Tower Bersama (TBIG:IJ) Heavy Debt, Operational Underperformance = TOWR:IJ Preferred

Indonesia

PT Saratoga Investama Sedaya Tbk is an active investment company focused on high-growth potential companies in Indonesia and Southeast Asia. It invests in sectors such as healthcare, digital infrastructure, consumer, green economy, energy, precious metals, and specialty logistics. The company was established in 1997 and is headquartered in Jakarta, Indonesia.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Saratoga Investama Sedaya (SRTG IJ)